Latest Uterine fibroids Stories
LIVERMORE, Calif., July 26 /PRNewswire/ -- Halt Medical, Inc. announced today that Robert J. Rubin, M.D. has been appointed to its Scientific Advisory Board. Dr. Rubin will also be a consultant to the company, helping to develop and implement comprehensive reimbursement strategies. Dr.
TORRANCE, Calif., July 21 /PRNewswire/ -- Due to fewer complications, minimally invasive robotic surgery has exploded in popularity and usage in the gynecology field.
Hospital named academic center of excellence for leading-edge gynecological surgery DALLAS, July 6 /PRNewswire-USNewswire/ -- Texas Health Presbyterian Hospital Dallas is the first hospital in Texas -- and one of only three in the United States -- to be named a Center of Excellence for gynecological surgery by the American Institute for Minimally Invasive Surgery (AIMIS). (Photo: http://www.newscom.com/cgi-bin/prnh/20100706/DC29919) (Photo: http://photos.prnewswire.com/prnh/20100706/DC29919)...
A new, effective, non-surgical treatment for uterine fibroids can help women with this condition maintain their fertility, an American scientist told the 26th annual meeting of the European Society of Human Reproduction and Embryology in Rome today (Wednesday).
ABBOTT PARK, Ill. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain.
LIVERMORE, Calif., June 15 /PRNewswire/ -- Halt Medical, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared the Halt 2000GI(TM) Electrosurgical System for soft tissue ablation using radiofrequency energy.
GENEVA, Switzerland, June 3, 2010 /PRNewswire/ -- - PEARL I Trial Meets Primary Efficacy and Safety Endpoints - PregLem Preparing for Submission to the European Medicines Agency in 2010 PregLem, the European specialty biopharmaceutical company focused on women's reproductive medicine, announces positive Phase III data from its second pivotal study (PEARL I) for its lead product Esmya (ulipristal acetate), as an effective treatment for uterine fibroids (myoma) - a condition that...
EDMONTON, May 11 /PRNewswire/ - IMBiotechnologies Ltd.
MR-guided focused ultrasound offers women another minimally invasive treatment to remove uterine fibroidsâ€”avoiding surgical myomectomy and hysterectomy
First global study indicates comparable fertility rates for minimally invasive UFE and 'gold standard' surgical myomectomy for women who want to have children after uterine fibroid treatment
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.